Analytical Data
-
Gene name
C1orf8
- Application
-
Alternative Names
TMEM59; C1orf8; HSPC001; UNQ169/PRO195; Transmembrane Protein 59; Liver membrane-bound Protein
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BXS4
-
Expression Region
37-323aa
-
AA Sequence
AFDSVLGDTASCHRACQLTYPLHTYPKEEELYACQRGCRLFSICQFVDDGIDLNRTKLECESACTEAYSQSDEQYACHLGCQNQLPFAELRQEQLMSLMPKMHLLFPLTLVRSFWSDMMDSAQSFITSSWTFYLQADDGKIVIFQSKPEIQYAPHLEQEPTNLRESSLSKMSYLQMRNSQAHRNFLEDGESDGFLRCLSLNSGWILTTTLVLSVMVLLWICCATVATAVEQYVPSEKLSIYGDLEFMNEQKLNRYPASSLVVVRSKTEDHEEAGPLPTKVNLAHSEI
-
Molecular Weight
35.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C1orf8, also known as the chromosome 1 open reading frame 8, has emerged as a significant focus of research due to its potential implications in various biological processes and diseases. Initially identified through genomic studies, C1orf8 is believed to encode a protein that plays a role in cellular functions, including growth, differentiation, and apoptosis. Its expression patterns have been linked to several types of cancer, prompting investigations into its role as a potential biomarker and therapeutic target. Recent studies have utilized recombinant protein techniques to produce C1orf8 in order to elucidate its structure-function relationship and interactions with other cellular molecules. This approach enables researchers to dissect the molecular mechanisms underlying its activity and ascertain its implications in oncogenesis and other pathologies. Moreover, advances in proteomic technologies have facilitated the study of C1orf8's post-translational modifications and their effects on protein function and stability. Understanding C1orf8 at the biochemical level could reveal novel insights into its contributions to disease mechanisms and lead to the development of targeted therapies. Therefore, the research surrounding C1orf8 recombinant protein not only enhances our understanding of its biological roles but also holds promise for future clinical applications in precision medicine.
